Literature DB >> 2764902

Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.

V Baron1, N Gautier, N Rochet, R Ballotti, B Rossi, S Saint-Pierre, E Van Obberghen, J Dolais-Kitabgi.   

Abstract

Anti-peptide antibodies directed against a highly-conserved sequence of the insulin receptor tyrosine kinase domain have been used to study the relationship between this specific region and kinase activation. Antibodies have been prepared by the injection into a rabbit of a synthetic peptide (P2) corresponding to residues 1110-1125 of the proreceptor. The peptide exhibits 88-95% sequence similarity with the corresponding sequence in the v-ros protein and in receptors for epidermal growth factor and for insulin-like growth factor 1. Two antibodies with different specificities could be separated from total antiserum obtained after immunization with P2. One antibody [anti-(P-Tyr)] cross-reacted with phosphotyrosine and immunoprecipitated solely autophosphorylated receptors. This antibody was shown to increase or decrease the receptor tyrosine kinase activity depending on its concentration. In all circumstances receptor autophosphorylation and substrate phosphorylation were modulated in a parallel fashion. The second antibody (anti-P2) failed to immunoprecipitate the insulin receptor, but was found to interact with both the peptide and the receptor by e.l.i.s.a. assay. Using a tyrosine co-polymer we found that anti-P2 activated the insulin receptor kinase leading to substrate phosphorylation at a level similar to that observed with insulin. This effect was additive to the hormonal effect. In contrast, receptor autophosphorylation was not modified by the anti-peptide. The differential effect of this anti-peptide further supports the idea that receptor autophosphorylation and kinase activity towards exogenous substrates might be independently regulated. Finally, our data suggest that conformational changes in the receptor tyrosine kinase domain may be sufficient for activation of its enzymic activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764902      PMCID: PMC1138740          DOI: 10.1042/bj2600749

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.

Authors:  Y Yarden; J A Escobedo; W J Kuang; T L Yang-Feng; T O Daniel; P M Tremble; E Y Chen; M E Ando; R N Harkins; U Francke
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation.

Authors:  R Herrera; O M Rosen
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

3.  Phosphorylation of synthetic insulin receptor peptides by the insulin receptor kinase and evidence that the preferred sequence containing Tyr-1150 is phosphorylated in vivo.

Authors:  L Stadtmauer; O M Rosen
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

Review 4.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

5.  A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.

Authors:  D Martin-Zanca; S H Hughes; M Barbacid
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

6.  Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system.

Authors:  M Kasuga; Y Zick; D L Blithe; M Crettaz; C R Kahn
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

7.  Phosphorylation of the hepatic insulin receptor: stimulating effect of insulin on intact cells and in a cell-free system.

Authors:  E Van Obberghen; A Kowalski
Journal:  FEBS Lett       Date:  1982-07-05       Impact factor: 4.124

8.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

9.  Insulin-stimulated tyrosine phosphorylation of the insulin receptor in detergent extracts of human placental membranes. Comparison to epidermal growth factor-stimulated phosphorylation.

Authors:  J Avruch; R A Nemenoff; P J Blackshear; M W Pierce; R Osathanondh
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

10.  Biochemical and morphological evidence that the insulin receptor is internalized with insulin in hepatocytes.

Authors:  M Fehlmann; J L Carpentier; A Le Cam; P Thamm; D Saunders; D Brandenburg; L Orci; P Freychet
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  3 in total

1.  Autoantibodies to the insulin receptor are infrequent findings in type 1 (insulin-dependent) diabetes mellitus of recent onset.

Authors:  N Rochet; J L Sadoul; B Ferrua; J Kubar; J F Tanti; P Bougnères; B Vialettes; E Van Obberghen; Y Le Marchand-Brustel; P Freychet
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

2.  Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.

Authors:  P Hainaut; A Kowalski; S Giorgetti; V Baron; E Van Obberghen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

3.  A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.

Authors:  R H Ganderton; K K Stanley; C E Field; M P Coghlan; M A Soos; K Siddle
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.